Description: |
Blocking the action of a particular protein in our skin could improve the treatment of skin cancers, according to a new study. The findings reveal part of the mechanisms responsible for the resistance of melanoma to anti-cancer treatments, and suggest that a particular protein in our bodies called RSK may be targeted in combination therapies to overcome drug resistance. [Source: EurekaAlert!]
|
|